• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nanog 作为肿瘤进展中的关键癌症干细胞标志物。

Nanog, as a key cancer stem cell marker in tumor progression.

机构信息

Department of Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Department of Plant Biology, Faculty of Natural Science, University of Tabriz, Iran.

出版信息

Gene. 2022 Jun 15;827:146448. doi: 10.1016/j.gene.2022.146448. Epub 2022 Mar 22.

DOI:10.1016/j.gene.2022.146448
PMID:35337852
Abstract

Cancer stem cells (CSCs) are a small population of malignant cells that induce tumor onset and development. CSCs share similar features with normal stem cells in the case of self-renewal and differentiation. They also contribute to chemoresistance and metastasis of cancer cells, leading to therapeutic failure. To identify CSCs, multiple cell surface markers have been characterized, including Nanog, which is found at high levels in different cancers. Recent studies have revealed that Nanog upregulation has a substantial association with the advanced stages and poor prognosis of malignancies, playing a pivotal role through tumorigenesis of multiple human cancers, including leukemia, liver, colorectal, prostate, ovarian, lung, head and neck, brain, pancreatic, gastric and breast cancers. Nanog through different signaling pathways, like JAK/STAT and Wnt/β-catenin pathways, induces stemness, self-renewal, metastasis, invasiveness, and chemoresistance of cancer cells. Some of these signaling pathways are common in various types of cancers, but some have been found in one or two cancers. Therefore, this review aimed to focus on the function of Nanog in multiple cancers based on recent studies surveying the suitable approaches to target Nanog and inhibit CSCs residing in tumors to gain favorable results from cancer treatments.

摘要

癌症干细胞(CSCs)是一小群恶性细胞,可诱导肿瘤的发生和发展。CSCs 在自我更新和分化方面与正常干细胞具有相似的特征。它们还导致癌细胞的化疗耐药性和转移,从而导致治疗失败。为了鉴定 CSCs,已经描述了多种细胞表面标志物,包括 Nanog,它在不同的癌症中高水平存在。最近的研究表明,Nanog 的上调与恶性肿瘤的晚期和预后不良有很大关系,通过多种人类癌症(包括白血病、肝、结直肠、前列腺、卵巢、肺、头颈部、脑、胰腺、胃和乳腺癌)的肿瘤发生发挥关键作用。Nanog 通过不同的信号通路,如 JAK/STAT 和 Wnt/β-catenin 通路,诱导癌细胞的干性、自我更新、转移、侵袭和化疗耐药性。这些信号通路中的一些在各种类型的癌症中是常见的,但有些仅在一种或两种癌症中发现。因此,本综述旨在根据最近研究中调查靶向 Nanog 和抑制肿瘤中 CSCs 的方法,重点关注 Nanog 在多种癌症中的功能,以获得癌症治疗的有利结果。

相似文献

1
Nanog, as a key cancer stem cell marker in tumor progression.Nanog 作为肿瘤进展中的关键癌症干细胞标志物。
Gene. 2022 Jun 15;827:146448. doi: 10.1016/j.gene.2022.146448. Epub 2022 Mar 22.
2
Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction.信号通路和 microRNAs,在癌症诱导过程中调控 NANOG 活性的指挥官。
Life Sci. 2020 Nov 1;260:118337. doi: 10.1016/j.lfs.2020.118337. Epub 2020 Aug 22.
3
The oncogenic potential of NANOG: An important cancer induction mediator.NANOG 的致癌潜能:一种重要的癌症诱导介质。
J Cell Physiol. 2021 Apr;236(4):2443-2458. doi: 10.1002/jcp.30063. Epub 2020 Sep 22.
4
NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.NANOGP8 是胃癌细胞干性、EMT、Wnt 通路、化疗耐药性和其他恶性表型的关键调节因子。
PLoS One. 2018 Apr 24;13(4):e0192436. doi: 10.1371/journal.pone.0192436. eCollection 2018.
5
RNA Polymerase II-Associated Factor 1 Regulates Stem Cell Features of Pancreatic Cancer Cells, Independently of the PAF1 Complex, via Interactions With PHF5A and DDX3.RNA 聚合酶 II 相关因子 1 通过与 PHF5A 和 DDX3 的相互作用,独立于 PAF1 复合物,调节胰腺癌细胞的干细胞特征。
Gastroenterology. 2020 Nov;159(5):1898-1915.e6. doi: 10.1053/j.gastro.2020.07.053. Epub 2020 Aug 8.
6
Nr5a2 promotes cancer stem cell properties and tumorigenesis in nonsmall cell lung cancer by regulating Nanog.Nr5a2 通过调节 Nanog 促进非小细胞肺癌的肿瘤干细胞特性和肿瘤发生。
Cancer Med. 2019 Mar;8(3):1232-1245. doi: 10.1002/cam4.1992. Epub 2019 Feb 10.
7
Insights into the gene: A propeller for stemness in primitive stem cells.对该基因的深入了解:原始干细胞干性的推进器。
Int J Biol Sci. 2016 Oct 25;12(11):1372-1381. doi: 10.7150/ijbs.16349. eCollection 2016.
8
RACK1 Promotes Self-Renewal and Chemoresistance of Cancer Stem Cells in Human Hepatocellular Carcinoma through Stabilizing Nanog.RACK1 通过稳定 Nanog 促进人肝癌肿瘤干细胞的自我更新和化疗耐药性。
Theranostics. 2019 Jan 24;9(3):811-828. doi: 10.7150/thno.29271. eCollection 2019.
9
Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4/Nanog NSCLC cells.抑制 Wnt/β-catenin 通路逆转 Oct4/Nanog NSCLC 细胞的多药耐药和 EMT。
Biomed Pharmacother. 2020 Jul;127:110225. doi: 10.1016/j.biopha.2020.110225. Epub 2020 May 16.
10
RNAi mediated silencing of Nanog expression suppresses the growth of human colorectal cancer stem cells.RNAi 介导的 Nanog 表达沉默抑制人结直肠癌细胞干细胞的生长。
Biochem Biophys Res Commun. 2021 Jan 1;534:254-260. doi: 10.1016/j.bbrc.2020.11.101. Epub 2020 Dec 4.

引用本文的文献

1
Cancer stem cells: landscape, challenges and emerging therapeutic innovations.癌症干细胞:现状、挑战与新兴治疗创新
Signal Transduct Target Ther. 2025 Aug 5;10(1):248. doi: 10.1038/s41392-025-02360-2.
2
Sensitisation of HeLa Cell Cultures to Xanthone Treatment by RNAi-Mediated Silencing of NANOG and STAT3.通过RNA干扰介导的NANOG和STAT3基因沉默使HeLa细胞培养物对氧杂蒽酮处理敏感化。
Curr Issues Mol Biol. 2025 Jul 9;47(7):529. doi: 10.3390/cimb47070529.
3
ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake.
ZMIZ1 乳酸化通过增加 Nanog 的转录活性影响细胞干性和胆固醇摄取,从而诱导乳腺癌对他莫昔芬耐药。
Cell Biol Toxicol. 2025 Jul 16;41(1):117. doi: 10.1007/s10565-025-10068-w.
4
Pluripotency genes of mammals: a network at work.哺乳动物的多能性基因:一个起作用的网络。
Front Bioeng Biotechnol. 2025 Jun 12;13:1578499. doi: 10.3389/fbioe.2025.1578499. eCollection 2025.
5
Nanomaterials targeting cancer stem cells to overcome drug resistance and tumor recurrence.靶向癌症干细胞以克服耐药性和肿瘤复发的纳米材料。
Front Oncol. 2025 Jun 6;15:1499283. doi: 10.3389/fonc.2025.1499283. eCollection 2025.
6
HPV16 E7 Enhances Cell Stemness via RTKN2-Mediated Activation of the NF-κB Pathway in Cervical Cancer.人乳头瘤病毒16型E7蛋白通过RTKN2介导的核因子κB信号通路激活增强宫颈癌的细胞干性
Biochem Genet. 2025 Jun 10. doi: 10.1007/s10528-025-11144-w.
7
Stemness reducible effects of glyasperin A against NCCIT teratocarcinomas.甘油asperin A对NCCIT畸胎癌的干性降低作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 6. doi: 10.1007/s00210-025-04343-0.
8
Tumor heterogeneity and resistance in glioblastoma: the role of stem cells.胶质母细胞瘤中的肿瘤异质性与耐药性:干细胞的作用
Apoptosis. 2025 May 15. doi: 10.1007/s10495-025-02123-y.
9
Combination therapies and novel delivery systems: a new frontier in overcoming TRAIL resistance in gastric cancer.联合疗法与新型给药系统:克服胃癌中TRAIL耐药性的新前沿。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 10. doi: 10.1007/s00210-025-04208-6.
10
SMAD2 linker phosphorylation impacts overall survival, proliferation, TGFβ1-dependent gene expression and pluripotency-related proteins in NSCLC.SMAD2接头磷酸化影响非小细胞肺癌的总生存期、增殖、TGFβ1依赖的基因表达以及多能性相关蛋白。
Br J Cancer. 2025 May 3. doi: 10.1038/s41416-025-02970-1.